Hemanth J. Varghese Joins Viatris as Chief Strategy Officer to Drive Growth

Viatris Welcomes Hemanth J. Varghese as Chief Strategy Officer

In a significant move to bolster its executive leadership team, Viatris Inc. has officially welcomed Hemanth J. Varghese as its new Chief Strategy Officer. Announced on April 14, 2025, this appointment is set to bring a wealth of experience and strategic insight to the company, as it embarks on ambitious plans for growth in the coming years.

Hemanth Varghese comes to Viatris with an impressive background in the healthcare sector, boasting over two decades of expertise in strategy, operations, and corporate development. His previous roles have positioned him to lead various growth initiatives and strategic transformations across renowned multinational healthcare companies. Before joining Viatris, Varghese served as President and Chief Operating Officer at Venus Concept, where he pushed the boundaries of medical aesthetic technology. He also fulfilled key positions at HLS Therapeutics, Endo International, and Valeant Pharmaceuticals, among others, solidifying his reputation as a formidable leader in the healthcare industry.

Scott A. Smith, CEO of Viatris, expressed enthusiasm about Varghese's new role, stating, "We are excited to welcome Hemanth to Viatris in the role of Chief Strategy Officer. Hemanth adds another valuable perspective to our Executive Leadership Team. I believe his skills and expertise will be integral as we continue to shape our company for growth in 2026 and beyond."

In his response, Varghese conveyed his excitement for the opportunity, stating, "I am honored to be joining Viatris at such a transformative time for the company. I'm looking forward to partnering with Scott, the Executive Leadership Team and others across the organization as we continue to build a strong company for the future."

About Viatris

Viatris Inc., a globally recognized healthcare company listed on Nasdaq (VTRS), has a unique business model that integrates the strengths of both generics and brands. With a commitment to improving global health outcomes, Viatris strives to empower individuals to lead healthier lives at every stage. The company operates with a mission that emphasizes access to high-quality medications for a diverse patient population, reaching approximately 1 billion patients worldwide annually.

With a comprehensive portfolio of medicines and a robust global supply chain, Viatris aims to address some of the world’s persistent healthcare challenges. The company maintains its headquarters in the United States, supplemented by operational centers in key global cities such as Pittsburgh, Shanghai, and Hyderabad, India.

As Varghese steps into his new role, the healthcare community watches closely, eager to see how his extensive background in strategic development will influence Viatris' trajectory toward growth and innovation. The forward-looking vision outlined by the executive leadership team reflects a commitment to not only maintaining operational excellence but also adapting to the evolving landscape of healthcare challenges.

In addition, Viatris has been expressive about the potential impact of external factors on its strategic plans, emphasizing awareness of the regulatory environments and market dynamics that can influence the healthcare sector. Forecasts suggest that under Varghese's leadership, Viatris aims to navigate these complexities effectively, positioning itself as a leader in bringing innovative healthcare solutions to market.

Stay tuned as Hemanth J. Varghese embarks on this new chapter with Viatris, bringing his vast expertise and visionary strategic insights that could shape the future of healthcare solutions globally.